Inside Next-Gen Platforms For Cell Therapy Manufacturing | Audience Q&A

In one of our most active Cell & Gene Live audience Q&As to date, Will Junker and Nick Siciliano provided detailed responses to several audience questions ranging in scope from reducing environmental control requirements with respect to total COGs for cell therapy manufacturing to the technologies that benefit in closing of processes, and much more.